Fundraising FoxCamden Partners — 2018 Investments
4 investments dated 2018 · listed companies and verified rows first · show all
Provider of K-12 distance learning curriculum and educational support services worldwide.
Hunt Valley, US
Steve L Gross(Chief Executive Officer)inPamela Chelden(Chief Financial Officer)Robert Henninger, Jr.(Director)Scott Soffen(Director)John Commack(Director)William Harrison(Director)
Co-investorsBonsal Capital
Designed Hemafuse, a manual autotransfusion device that recycles blood during internal bleeding without electricity.
Carolyn Yarina(Cofounder)
Co-investorsFINCA VenturesMaryland TEDCOTEDCOWhoa I Lp, By: Whoa VenturesRevolutionRise of the Rest Seed
HealthtechBaltimore, US
Carolyn Reed Yarina(Executive Officer, Director)Katherine Kirsch(Executive Officer, Director)Gillian Henker(Executive Officer, Director)in
Co-investorsBelle Impact FundCatalio Capital Management, LPWhoa I Lp, By: Whoa VenturesCatalio AccessGolden SeedsRevolution+1 more
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Hugo Peris(Founder and Chief Executive Officer)inEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)
BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)Guy Nohra(Director)in
Co-investorsCatalio Capital ManagementInveready Technology Investment GroupLifelinkStartXAlta PartnersEsperante Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.